Frankfurt Rhine-Main Metropolitan Area
20 year experience in the pharmaceutical industry in various positions ranging from: - Marketing (national as well as international) - Market Access & Reimbursement - Healtheconomics & Health Care Politics Assistant Professor lecturing on HTA and Principals of Healtheconomics at a jointly conduced course run by the University of Cardiff and the University of Applied Science Fresenius (Idstein) Specialties: Immunology & Oncology
Leading a team to develop, manage and execute pricing and reimbursement strategies for all our products (new products like Actair/Orylmyte, extensions, revisions …) in the dedicated regions (EU5, CEE, MEA, APAC) to achieve: • reimbursement in favorable terms for patients and Stallergenes Greer at national and regional level; (Pricing & Reimbursement Dossier development & filing; price negotiations) • fair prices for products of our portfolio across a diverse set of health care systems (e.g. Germany to Romania) • rebate contracts with sick funds in DE Strong collaboration with local market access teams & HQ – functions, Regulatory Affairs, Medical as well as commercial.
Public Health • Development of managed care solutions and their implementation involving health policy actors and care providers (health insurance funds, medical associations and patient associations). Attract public funds & project management Politics • Engagement with committees and association work. Focus on eHealth and occupational health management (BGM). Member of the Vfa Expert Group on Digitization Market Access • Analysis of care paths and strategic development of care approaches via data mining cooperations with health insurance companies (therapeutic areas immunology and haemato-oncology) • Health economic cost analysis to derive dossier strategies for early benefit assessment as well as expertise in reimbursement issues (laboratory diagnostics)
• Positioning AbbVie as new player towards political stakeholders by shaping the topic of "maintaining the ability to work" and bringing it to life • Sketching out and placing pharma-political demands within the framework of legislative procedures (e.g. prevention law) • Planning and implementation of tactics along themes such as "Maintaining the ability to work" through various formats such as medical training, world café formats, publications and founding of initiatives.
Leading strategic health projects in immunology
- Responsible for pricing and reimbursement of all pipeline and marketed products worldwide - Expertise in external reference pricing - In depth analyses on EU5 HTA readiness of our lead & pipeline candidates regarding nessacity and potential gaps - Strong knowlegde about Geman market (AMNOG, Orphans, Interaction G-BA-IQWiG)
- Leading a team to commercialize all Phase IIb development candidates (therapeutic areas rheumatology/dermatology, oncology) - Using top down competitive methodologies as well as buttom up patient tree driven approaches to develope sound sales scenarios as well as marketing strategies & expenses feeding in to NPV calculations - Strong cross functional approach with clinical research, regulatory and controlling - KOL roadmapping & Publication planning - Key deliverables: Successful partnering deal with Abbott